Diagnosis and treatment of small saphenous vein (SSV) insufficiency is of utmost importance for relieving chronic venous insufficiency symptoms. To investigate the efficacy and safety of five different treatment approaches among patients with SSV insufficiency. Two-center retrospective clinical study, conducted at cardiovascular surgery clinics in a local training and research hospital and a state hospital. A total of 282 extremities of 268 patients with SSV insufficiency alone who were treated for symptomatic varicose veins between January 2012 and January 2017 were included in the study. All extremities included in the study were divided into five groups as follows: high ligation + stripping; radiofrequency ablation (RFA); cyanoacrylate closure (CAC); and endovenous laser ablation (EVLA) at the wavelengths 980 nm and 1,470 nm. Although the recurrence rate at six months was similar among the treatment groups, we found significant differences in recurrence rates at one year, with lower rates in the CAC, RFA and 1,470 nm EVLA groups, compared with the other treatments (P = 0.005). No sural neuritis was observed in the CAC group. The pigmentation rate was higher in the two EVLA groups (980 nm and 1,470 nm). Our study results showed that although CAC, RFA and EVLA at 1,470 nm seemed to be effective methods for treating SSV insufficiency alone, CAC and RFA had better aesthetic results than EVLA at 1,470 nm. We consider that endovenous non-thermal techniques for treating SSV insufficiency may be preferable because of relatively low risk of nerve injury.
The off-pump coronary artery bypass (OPCAB) technique, which is used in order to avoid the side effects of cardiopulmonary bypass, is often questioned in terms of its efficacy and safety. Also, in this technique, surgeon experience plays a very important role. In this study, we share the results of our 606 OPCAB cases with an alternative retraction technique. This study was a retrospective analysis of OPCAB operations performed between January 2014 and December 2018. Patients were evaluated and operated on by a surgical team led by an experienced OPCAB surgeon with over 200 prior OPCAB surgeries. The study included 606 OPCAB cases, and 21.8% (132) were female and 78.2% (474) were male. Our mortality rate was 1.7% (n = 10) and only two patients suffered a cerebrovascular incident. A statistically significant difference was found between pre-operative and six-month postoperative left ventricular ejection fraction values (p < 0.01). The OPCAB technique can be performed with similar results to on-pump surgery when conducted by an experienced surgeon, as in our study.
Purpose: The aim of this study was to assess early and midterm results of the patients undergoing ultrasound-accelerated catheter-directed thrombolysis for the treatment of acute iliofemoral deep venous thrombosis without popliteal vein thrombosis. Materials and Methods: A total of 18 patients (11 males, 7 females; mean age: 51.89 +/- 16.29 years; range, 16 to 72 years) who were diagnosed with acute iliofemoral deep vein thrombosis between November 2014 and December 2015 were included in this retrospective cross-sectional study. Results: Complete thrombolysis was successful in 88.9% (n=16) and in % 11.1 (n=2) patients with partial clot lysis. No pulmonary embolism was seen, while bleeding at the catheter-insertion site was observed in one patient. In another patient, underlying lesions were successfully treated with balloon angioplasty. The mean follow-up was 31.56 +/- 3.35 (range, 25 to 37 months). Duplex ultrasound was performed at one month, six months, one year, and two years following intervention and the iliac vein patency rate was found to be 100%, while superficial femoral vein insufficiency was in 5.6% (n=1), 11.1% (n=2), 16.2% (n=3), and 16.2% (n=3), respectively. Conclusion: Based on our findings, ultrasound-accelerated catheter-directed thrombolysis is a safe and effective method for carefully selected patients with acute iliofemoral deep vein thrombosis without popliteal vein thrombosis.